University of Alberta taking health discoveries from cutting edge to clinic
UAlberta researchers have been tapped for $25M national network to help promising treatments prove their worth with investors. The VET analysis uses a combination of forecasting and cost effectiveness to inform which candidate technologies should be advanced to Phase 2 trials. December 22, 2014